Sironax Overview

  • Founded
  • 2018
  • Status
  • Private
  • Employees
  • 32
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $101M
Latest Deal Amount
  • Investors
  • 4

Sironax General Information


Developer of pharmaceuticals for inflammatory and neuro-degenerative diseases. The company researches apoptosis and other cell death pathways to develop quality pharmaceuticals, enabling healthcare professionals to prescribe advanced treatments to their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Floor 2-4, West Section, South Office Building 1
  • No. 26 Science Park Road, Huilongguan Town, Changping District
  • Beijing
  • China
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sironax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 30-Sep-2019 $101M 00000 Completed Startup
2. Early Stage VC Completed Startup
1. Early Stage VC Completed Startup
To view Sironax’s complete valuation and funding history, request access »

Sironax Executive Team (1)

Name Title Board Seat Contact Info
Zhiyuan Zhang Chief Scientific Officer & Co-Founder
To view Sironax’s complete executive team members history, request access »

Sironax Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sironax Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Eight Roads Venture Capital Minority 000 0000 000000 0
F-Prime Capital Venture Capital Minority 000 0000 000000 0
Apricot Capital (Shanghai) Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
To view Sironax’s complete investors history, request access »